Current role
Biotechnology · Healthcare
Board Member
2021-05-13–present
Alison L. Hannah
Board Member
Rigel Pharmaceuticals Inc (RIGL)Equibles does not estimate personal net worth.
Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get RIGL alertsAbout Alison L. Hannah
Alison L. Hannah is recorded as Board Member at Rigel Pharmaceuticals Inc (RIGL) since May 13, 2021. Rigel Pharmaceuticals Inc reported in an 8-K filed May 30, 2023 that Alison L. Hannah was appointed Director, effective May 25, 2023. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.
“Each of the three nominees for director, to serve until the Company's 2026 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows:”
Affiliation history
-
Current
2021-05-13–present
Company network
Leadership on record at Rigel Pharmaceuticals Inc
- Raul R. Rodriguez CEO, Board Member
- Raul Rodriguez CEO, Board Member
- Dean Schorno CFO
- Raymond Furey General Counsel
- Alison Hannah Board Member
- Alison Hannah, M.D. Board Member
- Brian L. Kotzkin Board Member
- Gary A. Lyons Board Member
- Gregg A. Lapointe Board Member
- Jane Wasman Board Member